S1PR3
Sphingosine-1-phosphate receptor 3 (S1PR3) is a G protein-coupled receptor that binds the bioactive lipid sphingosine-1-phosphate (S1P). It is part of the sphingosine-1-phosphate receptor family, which plays a crucial role in various physiological processes.
Structure[edit]
S1PR3 is a member of the G protein-coupled receptor (GPCR) superfamily, characterized by seven transmembrane domains. The receptor is encoded by the S1PR3 gene located on chromosome 9q22.1. The protein structure allows it to interact with sphingosine-1-phosphate, a signaling molecule involved in numerous cellular functions.
Function[edit]
S1PR3 is involved in the regulation of several physiological processes, including:
- Vascular development and angiogenesis
- Immune cell trafficking
- Cardiovascular function
- Inflammatory response
The receptor mediates its effects through coupling with different G proteins, leading to the activation of various downstream signaling pathways.
Expression[edit]
S1PR3 is expressed in a variety of tissues, including the endothelial cells of blood vessels, smooth muscle cells, and immune cells. Its expression pattern suggests a role in both vascular and immune system functions.
Clinical Significance[edit]
Alterations in S1PR3 signaling have been implicated in several pathological conditions, such as:
Research is ongoing to develop therapeutic agents targeting S1PR3 for the treatment of these conditions.
See Also[edit]
External Links[edit]
- S1PR3 on WikiMD
- S1PR3 Gene - NCBI
| Glycoconjugates, lipids, and glycolipids: sphingolipids and glycosphingolipids, and metabolic intermediates | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian